Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies

Por Cobb, Bryan, Heilek, Gabrielle, Vilchez, Regis A
Publicado em 2014

Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Por Zitzer, Heike, Heilek, Gabrielle, Truchon, Karine, Susser, Simone, Vermehren, Johannes, Sizmann, Dorothea, Cobb, Bryan, Sarrazin, Christoph
Publicado em 2013

Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1

Por Kopetzki, Erhard, Jekle, Andreas, Ji, Changhua, Rao, Eileen, Zhang, Jun, Fischer, Stephan, Cammack, Nick, Sankuratri, Surya, Heilek, Gabrielle
Publicado em 2008

Epitope Switching as a Novel Escape Mechanism of HIV to CCR5 Monoclonal Antibodies

Por Jekle, Andreas, Chhabra, Milloni, Lochner, Adriane, Meier, Sonja, Chow, Eugene, Brandt, Michael, Sankuratri, Surya, Cammack, Nick, Heilek, Gabrielle
Publicado em 2010

Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

Por Schanzer, Jürgen, Jekle, Andreas, Nezu, Junichi, Lochner, Adriane, Croasdale, Rebecca, Dioszegi, Marianna, Zhang, Jun, Hoffmann, Eike, Dormeyer, Wilma, Stracke, Jan, Schäfer, Wolfgang, Ji, Changhua, Heilek, Gabrielle, Cammack, Nick, Brandt, Michael, Umana, Pablo, Brinkmann, Ulrich
Publicado em 2011